Delusion and Hallucination in Parkinson's Disease: A Pilot Study of Clinical Features and Pathogenesis

Eugene LEE; Sun-Ju CHUNG; Sung-Reul KIM; Tae-Yeon LEE; Jae-Hong LEE; Myoung-Chong LEE.
Journal of the Korean Neurological Association ; : 312-317, 2007.
Artículo en Ko | WPRIM | ID: wpr-34781

Documentos relacionados

  1. Othello syndrome in Parkinson's disease: A diagnostic emergency of an underestimated condition.
  2. D<sub>2/3</sub> Agonist during Learning Potentiates Cued Risky Choice.
  3. Othello syndrome in Parkinson's disease: a systematic review and report of a case series.
  4. [Effects of switching from dopamine agonists to zonisamide on psychiatric and motor symptoms in patients with Parkinson's disease].
  5. Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa-Induced Dyskinesia.
  6. Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy Volunteers.
  7. Efficacy and safety of non-ergot dopamine-receptor agonists as an adjunct to levodopa in advanced Parkinson's disease: A network meta-analysis.
  8. Hippocampal subfield atrophy in patients with Parkinson's disease and psychosis.
  9. Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities.
  10. Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease.